Bermel RA - Search Results

1

Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study.

Bermel RA, Innus MD, Tjoa CW, Bakshi R. Bermel RA, et al. Neuroreport. 2003 Mar 3;14(3):335-9. doi: 10.1097/00001756-200303030-00008. Neuroreport. 2003. PMID: 12634479

2

Associations of sNfL with clinico-radiological measures in a large MS population.

Sotirchos ES, Fitzgerald KC, Singh CM, Smith MD, Reyes-Mantilla M, Hersh CM, Hyland MH, Canissario R, Simmons SB, Arrambide G, Montalban X, Comabella M, Naismith RT, Qiao M, Krupp LB, Nicholas JA, Akgün K, Ziemssen T, Rudick R, Fisher E, Bermel RA, Mowry EM, Calabresi PA. Sotirchos ES, et al. Among authors: bermel ra. Ann Clin Transl Neurol. 2023 Jan;10(1):84-97. doi: 10.1002/acn3.51704. Epub 2022 Nov 25. Ann Clin Transl Neurol. 2023. PMID: 36427295 Free PMC article.

3

Regional brain atrophy is associated with physical disability in multiple sclerosis: semiquantitative magnetic resonance imaging and relationship to clinical findings.

Bakshi R, Benedict RH, Bermel RA, Jacobs L. Bakshi R, et al. Among authors: bermel ra. J Neuroimaging. 2001 Apr;11(2):129-36. doi: 10.1111/j.1552-6569.2001.tb00022.x. J Neuroimaging. 2001. PMID: 11296581

4

T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study.

Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW, Fabiano AJ, Jacobs L. Bakshi R, et al. Among authors: bermel ra. Arch Neurol. 2002 Jan;59(1):62-8. doi: 10.1001/archneur.59.1.62. Arch Neurol. 2002. PMID: 11790232

5

Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis.

Bermel RA, Bakshi R, Tjoa C, Puli SR, Jacobs L. Bermel RA, et al. Arch Neurol. 2002 Feb;59(2):275-80. doi: 10.1001/archneur.59.2.275. Arch Neurol. 2002. PMID: 11843699

6

A semiautomated measure of whole-brain atrophy in multiple sclerosis.

Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R. Bermel RA, et al. J Neurol Sci. 2003 Apr 15;208(1-2):57-65. doi: 10.1016/s0022-510x(02)00425-2. J Neurol Sci. 2003. PMID: 12639726

7

Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity.

Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B, Fisher E, Munschauer FE 3rd, Bakshi R. Bermel RA, et al. Arch Neurol. 2005 Sep;62(9):1371-6. doi: 10.1001/archneur.62.9.1371. Arch Neurol. 2005. PMID: 16157744 Free PMC article.

8

Measurement of brain and spinal cord atrophy by magnetic resonance imaging as a tool to monitor multiple sclerosis.

Bakshi R, Dandamudi VS, Neema M, De C, Bermel RA. Bakshi R, et al. Among authors: bermel ra. J Neuroimaging. 2005;15(4 Suppl):30S-45S. doi: 10.1177/1051228405283901. J Neuroimaging. 2005. PMID: 16385017 Review.

9

The measurement and clinical relevance of brain atrophy in multiple sclerosis.

Bermel RA, Bakshi R. Bermel RA, et al. Lancet Neurol. 2006 Feb;5(2):158-70. doi: 10.1016/S1474-4422(06)70349-0. Lancet Neurol. 2006. PMID: 16426992 Review.

10

The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.

Bermel RA, Fisher E, Cohen JA. Bermel RA, et al. Neuroimaging Clin N Am. 2008 Nov;18(4):687-701, xi. doi: 10.1016/j.nic.2008.06.008. Neuroimaging Clin N Am. 2008. PMID: 19068409 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page